Harbour Capital Advisors’s Kailera Therapeutics KLRA Stock Holding History

Harbour Capital Advisors’s Portfolio KLRA Stock Details KLRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$343K	Buy	+16,570	New	+$364K	0.06%	236

Other funds holding KLRA

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Harbour Capital Advisors's KLRA Position: Q2 2026 in Review

Harbour Capital Advisors opened a new position in Kailera Therapeutics (KLRA) in Q2 2026: 16,570 shares worth $343K. The stake represents 0.06% of the portfolio and ranks #236 among its holdings.

2 funds tracked by Wall St. Rank hold KLRA as of Q2 2026.

Harbour Capital Advisors held 16,570 shares of Kailera Therapeutics worth $343K as of Q2 2026.
Kailera Therapeutics was a new Harbour Capital Advisors position in Q2 2026.
Kailera Therapeutics made up 0.06% of Harbour Capital Advisors's portfolio in Q2 2026, its #236 holding.
2 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q2 2026.

Based on Harbour Capital Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.